‘Lack of appetite’ in London drives another high-tech firm to Nasdaq April 10, 2024 In a statement to markets this morning, London-HQd e-therapeutics said it has "an intention to cancel its admission to AIM and subsequently explore the option of listing on NASDAQ in due course."
London loses another listed company as pharma riser goes private April 2, 2024 Shareholders will vote on the decision on 19 April, requiring 75 per cent to vote in favour of the move, it confirmed in a statement to markets this morning.
Another listed company plans to quit London’s AIM market – this is why March 27, 2024 Drug company C4X Discovery has announced plans to quit the London Stock Exchange's AIM.
European Green Transition picks London to dig for key metal success March 17, 2024 The group will focus on distressed or under-valued green assets across Europe
Cambridge tech firm Checkit halves losses as it eyes profitability February 15, 2024 Software company Checkit has said its path to profitability is moving faster than expected, after it has halved losses year on year.